98.40
Schlusskurs vom Vortag:
$97.45
Offen:
$98.4
24-Stunden-Volumen:
451.79K
Relative Volume:
0.26
Marktkapitalisierung:
$7.51B
Einnahmen:
$8.10B
Nettoeinkommen (Verlust:
$599.48M
KGV:
13.30
EPS:
7.3969
Netto-Cashflow:
$971.54M
1W Leistung:
-8.45%
1M Leistung:
+5.53%
6M Leistung:
-43.92%
1J Leistung:
-45.16%
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ICLR
Icon Plc
|
98.42 | 7.44B | 8.10B | 599.48M | 971.54M | 7.3969 |
|
TMO
Thermo Fisher Scientific Inc
|
469.73 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.60 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
572.36 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.63 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
284.72 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-23 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-18 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-17 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | Herabstufung | Truist | Buy → Hold |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-09 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-03 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
Capital World Investors Takes $39.97 Million Position in Icon Plc $ICLR - MarketBeat
Capital Research Global Investors Buys 67,480 Shares of Icon Plc $ICLR - MarketBeat
Franklin Resources Inc. Purchases 719,301 Shares of Icon Plc $ICLR - MarketBeat
Russell Investments Group Ltd. Buys 68,493 Shares of Icon Plc $ICLR - MarketBeat
Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More - AOL.com
Icon price target lowered to $120 from $200 at Citi - Bitget
Polen Global Growth Strategy Sold ICON plc (ICLR) Due to Short-Term Growth Challenges - Finviz
Icon earnings on deck amid accounting probe uncertainty - Investing.com Australia
Icon earnings on deck amid accounting probe uncertainty By Investing.com - Investing.com Canada
Icon Plc $ICLR Stake Lessened by Neuberger Berman Group LLC - MarketBeat
ICON plc options imply 4.1% move in share price post-earnings - TipRanks
Barclays cuts ICON stock price target on accounting uncertainty By Investing.com - Investing.com UK
Barclays cuts ICON stock price target on accounting uncertainty - Investing.com
Handelsbanken Fonder AB Sells 9,064 Shares of Icon Plc $ICLR - MarketBeat
ICON plc Under Investigation for Possible Securities Fraud - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plcICLR - PR Newswire
Jefferies Upgrades ICON Public Limited Company (ICLR) to Buy from Hold - Finviz
ICLR (NASDAQ: ICLR) files Form 144 for 566 vested restricted shares on 03/03/2026 - Stock Titan
71,675 Shares in Icon Plc $ICLR Purchased by Arvin Capital Management LP - MarketBeat
American Century Companies Inc. Cuts Holdings in Icon Plc $ICLR - MarketBeat
Finemark National Bank & Trust Has $458,000 Stake in Icon Plc $ICLR - MarketBeat
ICLR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Icon Plc (NASDAQ:ICLR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
ICON plcOrdinary Shares (NQ: ICLR - The Chronicle-Journal
ICON Plc (ICLR) Stock Analysis: Unpacking The 37% Upside Potential - DirectorsTalk Interviews
JPMorgan Chase & Co. Decreases Holdings in Icon Plc $ICLR - MarketBeat
ICON plc Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Icon Plc (NASDAQ:ICLR) Short Interest Down 29.2% in February - MarketBeat
Jefferies Bullish on ICON (ICLR) Despite Share Price Decline - Finviz
ICON plc Opens with a 5.16% Gain After Recent Decline of 44.25% - Markets Mojo
Icon plc under the microscope over ‘misstated’ clinical trial revenue - The Times
Keystone Investors PTE Ltd. Takes Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Icon (NASDAQ:ICLR) Downgraded by Zacks Research to "Strong Sell" - MarketBeat
Icon Plc $ICLR Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Westfield Capital Management Co. LP Has $69.36 Million Stake in Icon Plc $ICLR - MarketBeat
Ademi LLP Investigates Claims of Securities Fraud against ICON plc - ChartMill
Thornburg Investment Management Inc. Sells 17,435 Shares of Icon Plc $ICLR - MarketBeat
Internship for Life Science Students at ICON Careers | Opportunity for Life Science Students - BioTecNika
ICON’s Accounting Review And Legal Scrutiny Could Be A Game Changer For ICON (ICLR) - Sahm
Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plcICLR - marketscreener.com
Here is Why ICON Public Limited Company (ICLR) Offers an Impressive Upside - Finviz
ICON plc earnings delayed to April as accounting investigation unfolds By Investing.com - Investing.com Canada
Clinical Research Provider Icon Stock Crashes On Accounting Probe - AOL.com
ICON plc (ICLR) Stock Analysis: Exploring the 58% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ICLR: Jefferies Upgrades Icon with Lowered Price Target | ICLR S - GuruFocus
Aberdeen Group plc Lowers Position in Icon Plc $ICLR - MarketBeat
ICON PLC (ICON) soars 16% as analyst issues 'hold', $93 PT despite accounting concerns - MSN
Jefferies upgrades ICON stock on valuation despite lower target By Investing.com - Investing.com UK
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):